[{"NetIncomeLoss_1_Q3_USD":-29924000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":186000.0,"PaymentsToAcquireInvestments_3_Q3_USD":95195000.0,"PurchaseObligation_0_Q3_USD":177400000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-23433000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_3_Q3_pure":0.011,"EquitySecuritiesFvNiCost_0_Q3_USD":125000000.0,"HeldToMaturitySecuritiesNoncurrent_0_Q3_USD":128376000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":224666017.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_3_Q3_pure":0.904,"AccruedLiabilitiesCurrent_0_Q3_USD":29525000.0,"HeldToMaturitySecuritiesCurrent_0_Q3_USD":63924000.0,"LiabilitiesNoncurrent_0_Q3_USD":102603000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q3_USD":1700000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":62000.0,"InterestIncomeExpenseNonoperatingNet_3_Q3_USD":4972000.0,"InterestIncomeExpenseNonoperatingNet_1_Q3_USD":1280000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":4523000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":12560000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":48.64,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"OperatingLeaseRightOfUseAsset_0_Q3_USD":18450000.0,"ShareBasedCompensation_3_Q3_USD":42051000.0,"Assets_0_Q3_USD":734927000.0,"CommonStockSharesIssued_0_Q3_shares":104209000.0,"EquitySecuritiesFvNi_0_Q3_USD":126407000.0,"FurnitureAndFixturesGross_0_Q3_USD":1163000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":4624000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_3_Q3_USD":10490000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":2756000.0,"LossContingencyAccrualAtCarryingValue_0_Q3_USD":0.0,"AssetsCurrent_0_Q3_USD":525955000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":18434000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":43581000.0,"DepreciationAndAmortization_3_Q3_USD":5763000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":11.18,"DepreciationDepletionAndAmortization_3_Q3_USD":4500000.0,"CommonStockValue_0_Q3_USD":197000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_3_Q3_USD":-142000.0,"AccountsReceivableNetCurrent_0_Q3_USD":671000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":664000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":1707000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":13682000.0,"PrepaidExpenseCurrent_0_Q3_USD":7276000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":104099000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":103569000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q3_USD":1700000.0,"EarningsPerShareBasic_1_Q3_USD":-0.29,"EarningsPerShareBasic_3_Q3_USD":-0.75,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":36704000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":20.0,"DepreciationDepletionAndAmortization_1_Q3_USD":1600000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":4649000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_3_Q3_USD":140576000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":10490000.0,"MarketableSecuritiesCurrent_0_Q3_USD":126407000.0,"OperatingLeaseLiability_0_Q3_USD":24144000.0,"CapitalizedComputerSoftwareGross_0_Q3_USD":509000.0,"HeldToMaturitySecurities_0_Q3_USD":192300000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":1017949000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_3_Q3_USD":87130000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":22854000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":325981000.0,"OtherAssetsNoncurrent_0_Q3_USD":272000.0,"AmortizationOfIntangibleAssets_1_Q3_USD":400000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":1275000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":3208000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-29964000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-77430000.0,"OtherAssetsCurrent_0_Q3_USD":1696000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q3_USD":59325000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":964000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":2895000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":100004000.0,"LiabilitiesCurrent_0_Q3_USD":195434000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":4522000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":104099000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":103569000.0,"LeaseholdImprovementsGross_0_Q3_USD":42934000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":195341000.0,"AccountsPayableCurrent_0_Q3_USD":10037000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":-40000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":18549000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":42051000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_3_Q3_USD":34.86,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_3_Q3_shares":167609.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-29924000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-77474000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":44000.0,"NonoperatingIncomeExpense_3_Q3_USD":6679000.0,"NonoperatingIncomeExpense_1_Q3_USD":1944000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_3_Q3_pure":0.862,"NetIncomeLoss_3_Q3_USD":-77474000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":47786000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q3_USD":173212122.0,"HeldToMaturitySecuritiesFairValue_0_Q3_USD":195007000.0,"OperatingLeasePayments_3_Q3_USD":2200000.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":14088000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":981219.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_3_Q3_pure":0.004,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":436890000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":325981000.0,"ShortTermLeaseCost_3_Q3_USD":0.0,"ShortTermLeaseCost_1_Q3_USD":0.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.085,"HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_0_Q3_USD":2707000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":10490000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":20792000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q3_USD":1700000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q3_USD":1700000.0,"EarningsPerShareDiluted_1_Q3_USD":-0.29,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q3_USD":400000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1290000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":68578000.0,"CapitalUnitsAuthorized_0_Q3_shares":150000000.0,"PreferredStockSharesAuthorized_0_Q3_shares":5000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":3648000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":734927000.0,"OperatingLeaseCost_1_Q3_USD":1600000.0,"OperatingLeaseCost_3_Q3_USD":3600000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":10.69,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":65.57,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":150934000.0,"OperatingIncomeLoss_1_Q3_USD":-31868000.0,"OperatingIncomeLoss_3_Q3_USD":-84153000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":45891000.0,"OperatingExpenses_3_Q3_USD":184157000.0,"CommonStockSharesAuthorized_0_Q3_shares":145000000.0,"OperatingExpenses_1_Q3_USD":77759000.0,"ProfitLoss_1_Q3_USD":-29924000.0,"EarningsPerShareDiluted_3_Q3_USD":-0.75,"CommonStockSharesOutstanding_0_Q3_shares":104209347.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":-174000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":182398000.0,"MarketableSecurities_0_Q3_USD":126400000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-581318000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":2417915.0,"VariableLeaseCost_1_Q3_USD":100000.0,"VariableLeaseCost_3_Q3_USD":600000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":3576575.0,"IncreaseDecreaseInOtherOperatingLiabilities_3_Q3_USD":-702000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":15368000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":79749000.0,"PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_0_Q3_USD":39000000.0,"ProfitLoss_3_Q3_USD":-77474000.0,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q3_USD":2400000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":211392000.0,"Ticker":"ARWR","CIK":"879407","name":"ARROWHEAD PHARMACEUTICALS, INC.","OfficialName":"Arrowhead Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"4797362481.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210805"}]